Macquarie Group’s Ortho Clinical Diagnostics Holdings OCDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-41,177
Closed -$769K – 2654
2022
Q1
$769K Sell
41,177
-1,635,701
-98% -$29.4M ﹤0.01% 1591
2021
Q4
$35.9M Sell
1,676,878
-217,383
-11% -$4.28M 0.03% 595
2021
Q3
$35M Buy
1,894,261
+427,291
+29% +$8.6M 0.03% 617
2021
Q2
$31.4M Buy
+1,466,970
New +$29.8M 0.03% 666

Other funds holding OCDX

Macquarie Group's OCDX Position: Q2 2022 in Review

Macquarie Group sold out of Ortho Clinical Diagnostics Holdings (OCDX) in Q2 2022, closing a stake of 41,177 shares — an estimated $769K sold.

Macquarie Group first reported a position in OCDX in Q2 2021 and held it in 4 quarters. The position peaked at $35.9M in Q4 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • Macquarie Group reported no remaining Ortho Clinical Diagnostics Holdings position as of Q2 2022 after selling out during the quarter.
  • Macquarie Group sold 41,177 Ortho Clinical Diagnostics Holdings shares in Q2 2022, an estimated $769K.
  • Macquarie Group first reported a position in Ortho Clinical Diagnostics Holdings in Q2 2021 and held it in 4 quarters.
  • Macquarie Group's Ortho Clinical Diagnostics Holdings position peaked at $35.9M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings as of Q2 2022.

Based on Macquarie Group's 13F filing for Q2 2022, filed 15 Aug 2022.